LORNA MONAGHAN: Open Payments
NPI 1699434928 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$388 in 17 payments from 7 companies in 2025. Trend: 2023 $501 · 2024 $769 · 2025 $388
Food & beverage: $388
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $97 |
| Merck Sharp & Dohme LLC | 3 | $64 |
| Caris MPI, Inc. | 2 | $62 |
| Eisai Inc. | 3 | $58 |
| GlaxoSmithKline, LLC. | 2 | $43 |
| AstraZeneca Pharmaceuticals LP | 2 | $42 |
| PFIZER INC. | 1 | $21 |
Products named: ELAHERE, MI CANCER SEEK, Lenvima, JEMPERLI, KEYTRUDA, LYNPARZA, TIVDAK.
Industry payments across NE — which companies pay providers there.
